1
|
Shahrzad S, Aoyagi K, Winter A, Koyama A
and Bitsch I: Pharmacokinetics of gallic acid and its relative
bioavailability from tea in healthy humans. J Nutr. 131:1207–1210.
2001.PubMed/NCBI
|
2
|
Kang MS, Oh JS, Kang IC, Hong SJ and Choi
CH: Inhibitory effect of methyl gallate and gallic acid on oral
bacteria. J Microbiol. 46:744–750. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kratz JM, Andrighetti-Fröhner CR, Leal PC,
Leal PC, Nunes RJ, Yunes RA, Trybala E, Bergström T, Barardi CR and
Simões CM: Evaluation of anti-HSV-2 activity of gallic acid and
pentyl gallate. Biol Pharm Bull. 31:903–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
4
|
You BR, Kim SZ, Kim SH and Park WH: Gallic
acid-induced lung cancer cell death is accompanied by ROS increase
and glutathione depletion. Mol Cell Biochem. 357:295–303. 2011.
View Article : Google Scholar : PubMed/NCBI
|
5
|
You BR and Park WH: Gallic acid-induced
lung cancer cell death is related to glutathione depletion as well
as reactive oxygen species increase. Toxicol In Vitro.
24:1356–1362. 2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Inoue M, Sakaguchi N, Isuzugawa K, Tani H
and Ogihara Y: Role of reactive oxygen species in gallic
acid-induced apoptosis. Biol Pharm Bull. 23:1153–1157. 2000.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Agarwal C, Tyagi A and Agarwal R: Gallic
acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via
ATM-Chk2 activation, leading to cell cycle arrest, and induces
apoptosis in human prostate carcinoma DU145 cells. Mol Cancer Ther.
5:3294–3302. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Faried A, Kurnia D, Faried LS, Usman N,
Miyazaki T, Kato H and Kuwano H: Anticancer effects of gallic acid
isolated from Indonesian herbal medicine, Phaleria macrocarpa
(Scheff.) Boerl, on human cancer cell lines. Int J Oncol.
30:605–613. 2007.PubMed/NCBI
|
9
|
You BR, Moon HJ, Han YH and Park WH:
Gallic acid inhibits the growth of HeLa cervical cancer cells via
apoptosis and/or necrosis. Food Chem Toxicol. 48:1334–1340. 2010.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Chen HM, Wu YC, Chia YC, Chang FR, Hsu HK,
Hsieh YC, Chen CC and Yuan SS: Gallic acid, a major component of
Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer
activity in human prostate cancer cells. Cancer Lett. 286:161–171.
2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Apak R, Özyürek M, Güçlü K and Çapanoğlu
E: Antioxidant activity/capacity measurement. 3. Reactive oxygen
and nitrogen species (ROS/RNS) scavenging assays, oxidative stress
biomarkers, and chromatographic/chemometric assays. J Agric Food
Chem. 64:1046–1070. 2016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Hsieh SC, Wu CH, Wu CC, Yen JH, Liu MC,
Hsueh CM and Hsu SL: Gallic acid selectively induces the necrosis
of activated hepatic stellate cells via a calcium-dependent calpain
I activation pathway. Life Sci. 102:55–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Inoue M, Suzuki R, Sakaguchi N, Li Z,
Takeda T, Ogihara Y, Jiang BY and Chen Y: Selective induction of
cell death in cancer cells by gallic acid. Biol Pharm Bull.
18:1526–1530. 1995. View Article : Google Scholar : PubMed/NCBI
|
14
|
Sohi KK, Mittal N, Hundal MK and Khanduja
KL: Gallic acid, an antioxidant, exhibits antiapoptotic potential
in normal human lymphocytes: A Bcl-2 independent mechanism. J Nutr
Sci Vitaminol (Tokyo). 49:221–227. 2003. View Article : Google Scholar : PubMed/NCBI
|
15
|
Sameermahmood Z, Raji L, Saravanan T,
Vaidya A, Mohan V and Balasubramanyam M: Gallic acid protects
RINm5F beta-cells from glucolipotoxicity by its antiapoptotic and
insulin-secretagogue actions. Phytother Res. 24 Suppl 1:S83–S94.
2010. View
Article : Google Scholar : PubMed/NCBI
|
16
|
Strlic M, Radovic T, Kolar J and Pihlar B:
Anti- and prooxidative properties of gallic acid in fenton-type
systems. J Agric Food Chem. 50:6313–6317. 2002. View Article : Google Scholar : PubMed/NCBI
|
17
|
Sakagami H and Satoh K: Prooxidant action
of two antioxidants: Ascorbic acid and gallic acid. Anticancer Res.
17:221–224. 1997.PubMed/NCBI
|
18
|
Bassenge E: Endothelial function in
different organs. Prog Cardiovasc Dis. 39:209–228. 1996. View Article : Google Scholar : PubMed/NCBI
|
19
|
Irani K: Oxidant signaling in vascular
cell growth, death, and survival: A review of the roles of reactive
oxygen species in smooth muscle and endothelial cell mitogenic and
apoptotic signaling. Circ Res. 87:179–183. 2000. View Article : Google Scholar : PubMed/NCBI
|
20
|
Han YH and Park WH: Pyrogallol-induced
calf pulmonary arterial endothelial cell death via
caspase-dependent apoptosis and GSH depletion. Food Chem Toxicol.
48:558–563. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Han YH, Moon HJ, You BR and Park WH:
Propyl gallate inhibits the growth of calf pulmonary arterial
endothelial cells via glutathione depletion. Toxicol In Vitro.
24:1183–1189. 2010. View Article : Google Scholar : PubMed/NCBI
|
22
|
Park WH: Pyrogallol induces the death of
human pulmonary fibroblast cells through ROS increase and GSH
depletion. Int J Oncol. 49:785–792. 2016. View Article : Google Scholar : PubMed/NCBI
|
23
|
You BR, Kim SH and Park WH: Reactive
oxygen species, glutathione, and thioredoxin influence suberoyl
bishydroxamic acid-induced apoptosis in A549 lung cancer cells.
Tumour Biol. 36:3429–3439. 2015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Park WH: Anti-apoptotic effect of caspase
inhibitors on H2O2-treated HeLa cells through early suppression of
its oxidative stress. Oncol Rep. 31:2413–2421. 2014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Han YH, Kim SZ, Kim SH and Park WH:
Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the
changes of intracellular GSH levels rather than ROS levels. Lung
Cancer. 59:301–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
26
|
You BR, Shin HR, Han BR and Park WH: PX-12
induces apoptosis in Calu-6 cells in an oxidative stress-dependent
manner. Tumour Biol. 36:2087–2095. 2015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Han YH, Kim SH, Kim SZ and Park WH:
Caspase inhibitor decreases apoptosis in pyrogallol-treated lung
cancer Calu-6 cells via the prevention of GSH depletion. Int J
Oncol. 33:1099–1105. 2008.PubMed/NCBI
|
28
|
Park WH and Kim SH: Involvement of
reactive oxygen species and glutathione in gallic acid-induced
human umbilical vein endothelial cell death. Oncol Rep. 28:695–700.
2012. View Article : Google Scholar : PubMed/NCBI
|
29
|
You BR and Park WH: Gallic acid-induced
human pulmonary fibroblast cell death is accompanied by increases
in ROS level and GSH depletion. Drug Chem Toxicol. 34:38–44. 2011.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Ohno Y, Fukuda K, Takemura G, Toyota M,
Watanabe M, Yasuda N, Xinbin Q, Maruyama R, Akao S, Gotou K, et al:
Induction of apoptosis by gallic acid in lung cancer cells.
Anticancer Drugs. 10:845–851. 1999. View Article : Google Scholar : PubMed/NCBI
|
31
|
Estrela JM, Ortega A and Obrador E:
Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci.
43:143–181. 2006. View Article : Google Scholar : PubMed/NCBI
|
32
|
Han YH, Kim SZ, Kim SH and Park WH:
Intracellular GSH level is a factor in As4.1 juxtaglomerular cell
death by arsenic trioxide. J Cell Biochem. 104:995–1009. 2008.
View Article : Google Scholar : PubMed/NCBI
|
33
|
You BR and Park WH: Enhancement of gallic
acid-induced human pulmonary fibroblast cell death by N-acetyl
cysteine and L-buthionine sulfoximine. Hum Exp Toxicol. 30:992–999.
2011. View Article : Google Scholar : PubMed/NCBI
|
34
|
You BR and Park WH: MG132, a proteasome
inhibitor-induced calf pulmonary arterial endothelial cell growth
and death, are changed by MAPK inhibitors. Drug Chem Toxicol.
34:45–52. 2011. View Article : Google Scholar : PubMed/NCBI
|
35
|
Han YH, Kim SZ, Kim SH and Park WH:
Reactive oxygen species and glutathione level changes by a
proteasome inhibitor, MG132, partially affect calf pulmonary
arterial endothelial cell death. Drug Chem Toxicol. 33:403–409.
2010. View Article : Google Scholar : PubMed/NCBI
|